TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs11191865
log Bayes Factor = 1.95702
Chromosome 10   position 105,672,842  (GRCh37) Explore rs11191865 on Ensembl!
Variant rs11191865 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
D17 Benign lipomatous neoplasm
0.000 0.086 0.914
D10-D36 Benign neoplasms
0.000 0.091 0.909
D34 Benign neoplasm of thyroid gland
0.000 0.102 0.898
D18 Haemangioma and lymphangioma, any site
0.000 0.104 0.896
D32 Benign neoplasm of meninges
0.000 0.107 0.893
D35 Benign neoplasm of other and unspecified endocrine glands
0.000 0.107 0.893
D26 Other benign neoplasms of uterus
0.000 0.107 0.893
D17.0 Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck
0.000 0.109 0.891
D32.9 Meninges, unspecified
0.000 0.115 0.885
D17.5 Benign lipomatous neoplasm of intra-abdominal organs
0.000 0.118 0.882
D35.1 Parathyroid gland
0.000 0.119 0.881
D18.0 Haemangioma, any site
0.000 0.121 0.879
D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
0.000 0.136 0.864
D26.1 Corpus uteri
0.000 0.145 0.855
D26.0 Cervix uteri
0.000 0.177 0.823
D17.9 Benign lipomatous neoplasm, unspecified
0.000 0.185 0.815
D17.1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
0.000 0.235 0.765
D18.1 Lymphangioma, any site
0.000 0.242 0.758
D32.0 Cerebral meninges
0.000 0.258 0.742
D10 Benign neoplasm of mouth and pharynx
0.000 0.265 0.735
D14 Benign neoplasm of middle ear and respiratory system
0.000 0.272 0.728
D15 Benign neoplasm of other and unspecified intrathoracic organs
0.000 0.300 0.700
D17.7 Benign lipomatous neoplasm of other sites
0.000 0.305 0.695
D20 Benign neoplasm of soft tissue of retroperitoneum and peritoneum
0.000 0.315 0.685
D35.2 Pituitary gland
0.000 0.334 0.666
D19 Benign neoplasm of mesothelial tissue
0.000 0.348 0.652
D35.9 Endocrine gland, unspecified
0.000 0.360 0.640
D35.8 Pluriglandular involvement
0.000 0.360 0.640
D35.7 Other specified endocrine glands
0.000 0.360 0.640
D35.6 Aortic body and other paraganglia
0.000 0.360 0.640
D35.5 Carotid body
0.000 0.360 0.640
D35.4 Pineal gland
0.000 0.360 0.640
D35.3 Craniopharyngeal duct
0.000 0.360 0.640
D26.7 Other parts of uterus
0.000 0.360 0.640
D31 Benign neoplasm of eye and adnexa
0.000 0.378 0.622
D35.0 Adrenal gland
0.000 0.384 0.616
D10.3 Other and unspecified parts of mouth
0.000 0.385 0.615
D36 Benign neoplasm of other and unspecified sites
0.000 0.391 0.608
D26.9 Uterus, unspecified
0.000 0.397 0.603
D17.4 Benign lipomatous neoplasm of intrathoracic organs
0.000 0.410 0.589
D14.1 Larynx
0.000 0.426 0.574
D10.5 Other parts of oropharynx
0.000 0.427 0.573
D33 Benign neoplasm of brain and other parts of central nervous system
0.000 0.429 0.571
D14.3 Bronchus and lung
0.000 0.442 0.558
D10.9 Pharynx, unspecified
0.000 0.443 0.557
D17.3 Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites
0.000 0.444 0.556
D15.0 Thymus
0.000 0.447 0.553
D36.1 Peripheral nerves and autonomic nervous system
0.000 0.449 0.551
D10.1 Tongue
0.000 0.454 0.546
D24 Benign neoplasm of breast
0.000 0.458 0.542
D28 Benign neoplasm of other and unspecified female genital organs
0.000 0.459 0.541
D13 Benign neoplasm of other and ill-defined parts of digestive system
0.000 0.463 0.537
D10.7 Hypopharynx
0.000 0.473 0.527
D10.6 Nasopharynx
0.000 0.473 0.527
D10.2 Floor of mouth
0.000 0.473 0.527
D20.1 Peritoneum
0.000 0.475 0.524
D14.4 Respiratory system, unspecified
0.000 0.478 0.522
D14.2 Trachea
0.000 0.478 0.522
D10.4 Tonsil
0.000 0.481 0.518
D14.0 Middle ear, nasal cavity and accessory sinuses
0.000 0.483 0.517
D15.9 Intrathoracic organ, unspecified
0.000 0.498 0.502
D15.7 Other specified intrathoracic organs
0.000 0.498 0.502
D15.2 Mediastinum
0.000 0.498 0.502
D30 Benign neoplasm of urinary organs
0.000 0.500 0.500
D15.1 Heart
0.000 0.504 0.496
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.493 0.507 0.000
D20.0 Retroperitoneum
0.000 0.509 0.491
T43.5 Other and unspecified antipsychotics and neuroleptics
0.491 0.509 0.000
I67 Other cerebrovascular diseases
0.490 0.510 0.000
I61 Intracerebral haemorrhage
0.490 0.510 0.000
T43.2 Other and unspecified antidepressants
0.489 0.511 0.000
D21 Other benign neoplasms of connective and other soft tissue
0.000 0.512 0.488
I60-I69 Cerebrovascular diseases
0.482 0.518 0.000
I61.9 Intracerebral haemorrhage, unspecified
0.481 0.519 0.000
I67.9 Cerebrovascular disease, unspecified
0.478 0.522 0.000
D31.4 Ciliary body
0.000 0.526 0.474
D31.0 Conjunctiva
0.000 0.528 0.472
D19.9 Mesothelial tissue, unspecified
0.000 0.532 0.467
D19.7 Mesothelial tissue of other sites
0.000 0.532 0.467
D19.1 Mesothelial tissue of peritoneum
0.000 0.532 0.467
D19.0 Mesothelial tissue of pleura
0.000 0.532 0.467
D25 Leiomyoma of uterus
0.000 0.533 0.467
I61.8 Other intracerebral haemorrhage
0.456 0.544 0.000
D13.5 Extrahepatic bile ducts
0.000 0.547 0.453
D13.3 Other and unspecified parts of small intestine
0.000 0.548 0.452
F31 Bipolar affective disorder
0.447 0.553 0.000
D31.9 Eye, unspecified
0.000 0.554 0.446
D31.6 Orbit, unspecified
0.000 0.554 0.446
D31.5 Lachrymal gland and duct
0.000 0.554 0.446
D31.1 Cornea
0.000 0.554 0.446
I61.2 Intracerebral haemorrhage in hemisphere, unspecified
0.446 0.554 0.000
D33.2 Brain, unspecified
0.000 0.555 0.445
D29 Benign neoplasm of male genital organs
0.000 0.562 0.438
I67.8 Other specified cerebrovascular diseases
0.436 0.564 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.435 0.565 0.000
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction
0.434 0.566 0.000
F31.9 Bipolar affective disorder, unspecified
0.431 0.569 0.000
D28.0 Vulva
0.000 0.573 0.427
D11 Benign neoplasm of major salivary glands
0.000 0.580 0.420
D25.2 Subserosal leiomyoma of uterus
0.000 0.583 0.417
I62 Other nontraumatic intracranial haemorrhage
0.412 0.588 0.000
D13.4 Liver
0.000 0.589 0.411
D33.0 Brain, supratentorial
0.000 0.589 0.411
D33.9 Central nervous system, unspecified
0.000 0.590 0.410
D33.7 Other specified parts of central nervous system
0.000 0.590 0.410
D33.1 Brain, infratentorial
0.000 0.590 0.410
I67.2 Cerebral atherosclerosis
0.406 0.594 0.000
D31.2 Retina
0.000 0.596 0.404
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms
0.403 0.597 0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression
0.400 0.600 0.000
F31.6 Bipolar affective disorder, current episode mixed
0.400 0.600 0.000
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms
0.399 0.601 0.000
D30.0 Kidney
0.000 0.604 0.396
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms
0.396 0.604 0.000
I67.7 Cerebral arteritis, not elsewhere classified
0.396 0.604 0.000
I64 Stroke, not specified as haemorrhage or infarction
0.396 0.604 0.000
D21.1 Connective and other soft tissue of upper limb, including shoulder
0.000 0.606 0.394
D10.0 Lip
0.000 0.606 0.394
D31.3 Choroid
0.000 0.610 0.390
I67.1 Cerebral aneurysm, nonruptured
0.389 0.611 0.000
F30-F39 Mood [affective] disorders
0.388 0.612 0.000
D28.9 Female genital organ, unspecified
0.000 0.612 0.388
I67.6 Nonpyogenic thrombosis of intracranial venous system
0.388 0.612 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.381 0.619 0.000
I61.6 Intracerebral haemorrhage, multiple localised
0.381 0.619 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.380 0.620 0.000
D28.1 Vagina
0.000 0.620 0.380
I61.0 Intracerebral haemorrhage in hemisphere, subcortical
0.377 0.623 0.000
D13.9 Ill-defined sites within the digestive system
0.000 0.624 0.376
I66.4 Occlusion and stenosis of multiple and bilateral cerebral arteries
0.376 0.624 0.000
T43.9 Psychotropic drug, unspecified
0.376 0.624 0.000
T43.6 Psychostimulants with abuse potential
0.376 0.624 0.000
Chapter V Mental and behavioural disorders
0.375 0.625 0.000
D36.9 Benign neoplasm of unspecified site
0.000 0.627 0.373
D36.7 Other specified sites
0.000 0.628 0.372
D32.1 Spinal meninges
0.001 0.634 0.365
F31.7 Bipolar affective disorder, currently in remission
0.364 0.636 0.000
I66.8 Occlusion and stenosis of other cerebral artery
0.364 0.636 0.000
D33.4 Spinal cord
0.000 0.636 0.363
D21.5 Connective and other soft tissue of pelvis
0.000 0.639 0.361
I67.4 Hypertensive encephalopathy
0.361 0.639 0.000
D13.7 Endocrine pancreas
0.000 0.639 0.361
F40-F48 Neurotic, stress-related and somatoform disorders
0.359 0.641 0.000
I62.1 Nontraumatic extradural haemorrhage
0.359 0.641 0.000
D30.9 Urinary organ, unspecified
0.000 0.641 0.358
D30.7 Other urinary organs
0.000 0.641 0.358
D30.2 Ureter
0.000 0.641 0.358
D30.1 Renal pelvis
0.000 0.641 0.358
D21.3 Connective and other soft tissue of thorax
0.000 0.642 0.358
I67.0 Dissection of cerebral arteries, nonruptured
0.357 0.643 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.357 0.643 0.000
D21.0 Connective and other soft tissue of head, face and neck
0.000 0.645 0.355
F43 Reaction to severe stress, and adjustment disorders
0.355 0.645 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.353 0.646 0.000
F60-F69 Disorders of adult personality and behaviour
0.353 0.647 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.353 0.647 0.000
I67.5 Moyamoya disease
0.352 0.648 0.000
I67.3 Progressive vascular leukoencephalopathy
0.352 0.648 0.000
D11.7 Other major salivary glands
0.000 0.651 0.349
I68 Cerebrovascular disorders in diseases classified elsewhere
0.347 0.653 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.347 0.653 0.000
I61.3 Intracerebral haemorrhage in brain stem
0.347 0.653 0.000
F43.1 Posttraumatic stress disorder
0.346 0.654 0.000
I62.9 Intracranial haemorrhage (nontraumatic), unspecified
0.345 0.655 0.000
D13.6 Pancreas
0.000 0.660 0.339
D30.4 Urethra
0.000 0.660 0.339
D21.9 Connective and other soft tissue, unspecified
0.000 0.663 0.337
D13.0 Oesophagus
0.000 0.664 0.336
D28.7 Other specified female genital organs
0.000 0.665 0.335
D21.6 Connective and other soft tissue of trunk, unspecified
0.000 0.668 0.331
I61.5 Intracerebral haemorrhage, intraventricular
0.330 0.670 0.000
D33.3 Cranial nerves
0.000 0.673 0.327
F60 Specific personality disorders
0.327 0.673 0.000
I61.1 Intracerebral haemorrhage in hemisphere, cortical
0.326 0.674 0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders
0.325 0.675 0.000
D29.3 Epididymis
0.000 0.675 0.325
D13.1 Stomach
0.000 0.678 0.322
F38 Other mood [affective] disorders
0.319 0.681 0.000
I66.9 Occlusion and stenosis of unspecified cerebral artery
0.319 0.681 0.000
I66.3 Occlusion and stenosis of cerebellar arteries
0.318 0.682 0.000
F33 Recurrent depressive disorder
0.318 0.682 0.000
F60.3 Emotionally unstable personality disorder
0.318 0.682 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.316 0.684 0.000
D29.9 Male genital organ, unspecified
0.000 0.685 0.314
D29.7 Other male genital organs
0.000 0.685 0.314
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.313 0.687 0.000
F34 Persistent mood [affective] disorders
0.313 0.687 0.000
D21.4 Connective and other soft tissue of abdomen
0.000 0.687 0.312
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction
0.312 0.688 0.000
I66.2 Occlusion and stenosis of posterior cerebral artery
0.311 0.689 0.000
I66.1 Occlusion and stenosis of anterior cerebral artery
0.311 0.689 0.000
F43.0 Acute stress reaction
0.310 0.690 0.000
F80-F89 Disorders of psychological development
0.309 0.691 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.308 0.692 0.000
D29.4 Scrotum
0.000 0.695 0.305
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.303 0.697 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.298 0.702 0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors
0.298 0.702 0.000
F31.8 Other bipolar affective disorders
0.296 0.704 0.000
F69 Unspecified disorder of adult personality and behaviour
0.295 0.705 0.000
F48 Other neurotic disorders
0.294 0.706 0.000
T36 Poisoning by systemic antibiotics
0.294 0.706 0.000
F31.0 Bipolar affective disorder, current episode hypomanic
0.291 0.708 0.000
D28.2 Uterine tubes and ligaments
0.000 0.709 0.291
I66.0 Occlusion and stenosis of middle cerebral artery
0.288 0.712 0.000
F23 Acute and transient psychotic disorders
0.287 0.713 0.000
T39.0 Salicylates
0.286 0.714 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.286 0.714 0.000
F42 Obsessive-compulsive disorder
0.282 0.718 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.281 0.719 0.000
T46.1 Calcium-channel blockers
0.280 0.720 0.000
I61.4 Intracerebral haemorrhage in cerebellum
0.278 0.722 0.000
F80 Specific developmental disorders of speech and language
0.278 0.722 0.000
D29.0 Penis
0.000 0.722 0.278
F70-F79 Mental retardation
0.276 0.724 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.273 0.727 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.272 0.727 0.000
I65.0 Occlusion and stenosis of vertebral artery
0.270 0.730 0.000
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.270 0.730 0.000
F00-F09 Organic, including symptomatic, mental disorders
0.270 0.730 0.000
F25 Schizoaffective disorders
0.269 0.731 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.269 0.731 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.268 0.731 0.000
D29.2 Testis
0.000 0.732 0.268
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms
0.267 0.732 0.000
D36.0 Lymph nodes
0.001 0.733 0.267
F61 Mixed and other personality disorders
0.267 0.733 0.000
F41 Other anxiety disorders
0.266 0.734 0.000
F68 Other disorders of adult personality and behaviour
0.265 0.735 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.264 0.736 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.263 0.736 0.000
F48.9 Neurotic disorder, unspecified
0.261 0.739 0.000
F41.2 Mixed anxiety and depressive disorder
0.261 0.739 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.260 0.740 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.260 0.740 0.000
D25.9 Leiomyoma of uterus, unspecified
0.000 0.741 0.259
F43.2 Adjustment disorders
0.259 0.741 0.000
F33.0 Recurrent depressive disorder, current episode mild
0.259 0.741 0.000
F80.1 Expressive language disorder
0.257 0.743 0.000
T39.4 Antirheumatics, not elsewhere classified
0.256 0.744 0.000
T39.2 Pyrazolone derivatives
0.256 0.744 0.000
F34.1 Dysthymia
0.256 0.744 0.000
F43.8 Other reactions to severe stress
0.254 0.746 0.000
F23.9 Acute and transient psychotic disorder, unspecified
0.254 0.746 0.000
I63 Cerebral infarction
0.254 0.746 0.000
F66 Psychological and behavioural disorders associated with sexual development and orientation
0.253 0.746 0.000
F65 Disorders of sexual preference
0.253 0.746 0.000
F63 Habit and impulse disorders
0.253 0.746 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.253 0.747 0.000
T46.7 Peripheral vasodilators
0.253 0.747 0.000
F60.6 Anxious [avoidant] personality disorder
0.253 0.747 0.000
F38.8 Other specified mood [affective] disorders
0.252 0.748 0.000
F38.0 Other single mood [affective] disorders
0.252 0.748 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.252 0.748 0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms
0.252 0.748 0.000
F60.9 Personality disorder, unspecified
0.251 0.749 0.000
I68.0 Cerebral amyloid angiopathy
0.250 0.750 0.000
F33.1 Recurrent depressive disorder, current episode moderate
0.250 0.750 0.000
F62 Enduring personality changes, not attributable to brain damage and disease
0.249 0.751 0.000
I68.8 Other cerebrovascular disorders in diseases classified elsewhere
0.249 0.751 0.000
I68.2 Cerebral arteritis in other diseases classified elsewhere
0.249 0.751 0.000
I68.1 Cerebral arteritis in infectious and parasitic diseases classified elsewhere
0.249 0.751 0.000
F21 Schizotypal disorder
0.249 0.751 0.000
D29.1 Prostate
0.000 0.754 0.246
F03 Unspecified dementia
0.246 0.754 0.000
D16 Benign neoplasm of bone and articular cartilage
0.001 0.755 0.245
I60 Subarachnoid haemorrhage
0.245 0.755 0.000
F33.8 Other recurrent depressive disorders
0.242 0.758 0.000
F43.9 Reaction to severe stress, unspecified
0.242 0.758 0.000
T47.0 Histamine H(2)-receptor antagonists
0.242 0.758 0.000
D23 Other benign neoplasms of skin
0.000 0.760 0.240
F50 Eating disorders
0.237 0.763 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.237 0.763 0.000
F60.0 Paranoid personality disorder
0.236 0.764 0.000
F44 Dissociative [conversion] disorders
0.235 0.765 0.000
F29 Unspecified nonorganic psychosis
0.235 0.765 0.000
I65.1 Occlusion and stenosis of basilar artery
0.235 0.765 0.000
F60.4 Histrionic personality disorder
0.235 0.765 0.000
F60.1 Schizoid personality disorder
0.235 0.765 0.000
F06 Other mental disorders due to brain damage and dysfunction and to physical disease
0.234 0.766 0.000
D25.1 Intramural leiomyoma of uterus
0.000 0.767 0.233
F28 Other nonorganic psychotic disorders
0.233 0.767 0.000
F24 Induced delusional disorder
0.233 0.767 0.000
F52 Sexual dysfunction, not caused by organic disorder or disease
0.232 0.768 0.000
T48.5 Anti-common-cold drugs
0.231 0.769 0.000
F81 Specific developmental disorders of scholastic skills
0.230 0.770 0.000
F25.0 Schizoaffective disorder, manic type
0.230 0.770 0.000
F34.0 Cyclothymia
0.229 0.771 0.000
F38.1 Other recurrent mood [affective] disorders
0.229 0.771 0.000
F64 Gender identity disorders
0.227 0.772 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.226 0.774 0.000
T47.2 Stimulant laxatives
0.226 0.774 0.000
F34.9 Persistent mood [affective] disorder, unspecified
0.224 0.775 0.000
F34.8 Other persistent mood [affective] disorders
0.224 0.775 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.224 0.775 0.000
I65.9 Occlusion and stenosis of unspecified precerebral artery
0.224 0.776 0.000
I65.8 Occlusion and stenosis of other precerebral artery
0.224 0.776 0.000
T36.8 Other systemic antibiotics
0.224 0.776 0.000
F33.4 Recurrent depressive disorder, currently in remission
0.224 0.776 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.223 0.776 0.000
I62.0 Subdural haemorrhage (acute) (nontraumatic)
0.223 0.777 0.000
F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified
0.223 0.777 0.000
T36.4 Tetracyclines
0.222 0.778 0.000
F89 Unspecified disorder of psychological development
0.222 0.778 0.000
F88 Other disorders of psychological development
0.222 0.778 0.000
F83 Mixed specific developmental disorders
0.222 0.778 0.000
F82 Specific developmental disorder of motor function
0.222 0.778 0.000
T47.6 Antidiarrhoeal drugs
0.219 0.781 0.000
D23.2 Skin of ear and external auricular canal
0.000 0.781 0.219
F42.0 Predominantly obsessional thoughts or ruminations
0.218 0.782 0.000
F25.1 Schizoaffective disorder, depressive type
0.218 0.782 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.217 0.783 0.000
T48.4 Expectorants
0.217 0.783 0.000
T48.3 Antitussives
0.217 0.783 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.217 0.783 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.217 0.783 0.000
T48.0 Oxytocic drugs
0.217 0.783 0.000
I63.2 Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
0.216 0.784 0.000
F42.1 Predominantly compulsive acts [obsessional rituals]
0.215 0.784 0.000
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction
0.215 0.785 0.000
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia
0.214 0.786 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.214 0.786 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.214 0.786 0.000
T47.7 Emetics
0.214 0.786 0.000
T47.5 Digestants
0.214 0.786 0.000
T47.3 Saline and osmotic laxatives
0.214 0.786 0.000
F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors
0.214 0.786 0.000
F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere
0.214 0.786 0.000
F60.7 Dependent personality disorder
0.213 0.787 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.213 0.787 0.000
F48.8 Other specified neurotic disorders
0.211 0.789 0.000
F48.1 Depersonalisation-derealisation syndrome
0.211 0.789 0.000
T36.9 Systemic antibiotic, unspecified
0.211 0.789 0.000
T36.7 Antifungal antibiotics, systemically used
0.211 0.789 0.000
T36.6 Rifamycins
0.211 0.789 0.000
T36.5 Aminoglycosides
0.211 0.789 0.000
T36.2 Chloramphenicol group
0.211 0.789 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.211 0.789 0.000
T36.0 Penicillins
0.211 0.789 0.000
F23.3 Other acute predominantly delusional psychotic disorders
0.210 0.789 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.210 0.789 0.000
F55 Abuse of non-dependence-producing substances
0.210 0.790 0.000
F40 Phobic anxiety disorders
0.210 0.790 0.000
F20 Schizophrenia
0.209 0.791 0.000
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms
0.209 0.791 0.000
F60.8 Other specific personality disorders
0.208 0.792 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.208 0.792 0.000
D23.6 Skin of upper limb, including shoulder
0.000 0.792 0.208
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.207 0.793 0.000
T36.3 Macrolides
0.206 0.793 0.000
F60.5 Anankastic personality disorder
0.206 0.794 0.000
F23.8 Other acute and transient psychotic disorders
0.206 0.794 0.000
F23.2 Acute schizophrenia-like psychotic disorder
0.206 0.794 0.000
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia
0.206 0.794 0.000
I65.3 Occlusion and stenosis of multiple and bilateral precerebral arteries
0.205 0.795 0.000
F79 Unspecified mental retardation
0.205 0.795 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.204 0.796 0.000
F52.2 Failure of genital response
0.203 0.797 0.000
F42.8 Other obsessive-compulsive disorders
0.202 0.797 0.000
F42.2 Mixed obsessional thoughts and acts
0.202 0.797 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.203 0.797 0.000
F68.1 Intentional production or feigning of symptoms or disabilities, either physical or psychological [factitious disorder]
0.201 0.798 0.000
I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic
0.201 0.799 0.000
F41.3 Other mixed anxiety disorders
0.201 0.799 0.000
F42.9 Obsessive-compulsive disorder, unspecified
0.201 0.799 0.000
F60.2 Dissocial personality disorder
0.200 0.800 0.000
I60.4 Subarachnoid haemorrhage from basilar artery
0.200 0.800 0.000
F50.0 Anorexia nervosa
0.200 0.800 0.000
F80.9 Developmental disorder of speech and language, unspecified
0.199 0.800 0.000
F80.8 Other developmental disorders of speech and language
0.199 0.800 0.000
F80.3 Acquired aphasia with epilepsy [Landau-Kleffner]
0.199 0.800 0.000
F80.0 Specific speech articulation disorder
0.199 0.800 0.000
F99-F99 Unspecified mental disorder
0.199 0.801 0.000
D23.4 Skin of scalp and neck
0.000 0.801 0.199
F06.7 Mild cognitive disorder
0.199 0.801 0.000
F78 Other mental retardation
0.198 0.802 0.000
F73 Profound mental retardation
0.198 0.802 0.000
F72 Severe mental retardation
0.198 0.802 0.000
F71 Moderate mental retardation
0.198 0.802 0.000
F70 Mild mental retardation
0.198 0.802 0.000
F39 Unspecified mood [affective] disorder
0.198 0.802 0.000
D16.9 Bone and articular cartilage, unspecified
0.000 0.802 0.198
F41.0 Panic disorder [episodic paroxysmal anxiety]
0.198 0.802 0.000
F09 Unspecified organic or symptomatic mental disorder
0.198 0.802 0.000
F95 Tic disorders
0.197 0.803 0.000
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation
0.197 0.803 0.000
I60.3 Subarachnoid haemorrhage from posterior communicating artery
0.197 0.803 0.000
T38.1 Thyroid hormones and substitutes
0.196 0.803 0.000
T41.5 Therapeutic gases
0.196 0.804 0.000
T41.4 Anaesthetic, unspecified
0.196 0.804 0.000
T41.3 Local anaesthetics
0.196 0.804 0.000
T41.2 Other and unspecified general anaesthetics
0.196 0.804 0.000
T41.1 Intravenous anaesthetics
0.196 0.804 0.000
T41.0 Inhaled anaesthetics
0.196 0.804 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.195 0.804 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.195 0.804 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.195 0.804 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.195 0.804 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.195 0.804 0.000
T44.0 Anticholinesterase agents
0.195 0.804 0.000
F80.2 Receptive language disorder
0.195 0.804 0.000
F51 Nonorganic sleep disorders
0.194 0.805 0.000
F94 Disorders of social functioning with onset specific to childhood and adolescence
0.194 0.806 0.000
F93 Emotional disorders with onset specific to childhood
0.194 0.806 0.000
F92 Mixed disorders of conduct and emotions
0.194 0.806 0.000
F91 Conduct disorders
0.194 0.806 0.000
F90 Hyperkinetic disorders
0.194 0.806 0.000
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances
0.194 0.806 0.000
F25.8 Other schizoaffective disorders
0.193 0.807 0.000
T49.9 Topical agent, unspecified
0.193 0.807 0.000
T49.8 Other topical agents
0.193 0.807 0.000
T49.7 Dental drugs, topically applied
0.193 0.807 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.193 0.807 0.000
T49.5 Ophthalmological drugs and preparations
0.193 0.807 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.193 0.807 0.000
T49.3 Emollients, demulcents and protectants
0.193 0.807 0.000
T49.2 Local astringents and local detergents
0.193 0.807 0.000
T49.1 Antipruritics
0.193 0.807 0.000
T47.4 Other laxatives
0.192 0.808 0.000
D13.2 Duodenum
0.000 0.808 0.191
F98 Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.191 0.808 0.000
F33.9 Recurrent depressive disorder, unspecified
0.190 0.810 0.000
F68.8 Other specified disorders of adult personality and behaviour
0.190 0.810 0.000
F68.0 Elaboration of physical symptoms for psychological reasons
0.190 0.810 0.000
T38.9 Other and unspecified hormone antagonists
0.189 0.811 0.000
T38.7 Androgens and anabolic congeners
0.189 0.811 0.000
T38.5 Other oestrogens and progestogens
0.189 0.811 0.000
T38.4 Oral contraceptives
0.189 0.811 0.000
T38.2 Antithyroid drugs
0.189 0.811 0.000
T38.0 Glucocorticoids and synthetic analogues
0.189 0.811 0.000
F06.8 Other specified mental disorders due to brain damage and dysfunction and to physical disease
0.189 0.811 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.188 0.811 0.000
I60.2 Subarachnoid haemorrhage from anterior communicating artery
0.188 0.812 0.000
F22 Persistent delusional disorders
0.186 0.814 0.000
F44.4 Dissociative motor disorders
0.185 0.815 0.000
I63.8 Other cerebral infarction
0.184 0.816 0.000
F50.2 Bulimia nervosa
0.184 0.816 0.000
D16.1 Short bones of upper limb
0.000 0.817 0.183
F01 Vascular dementia
0.183 0.817 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.183 0.817 0.000
I63.1 Cerebral infarction due to embolism of precerebral arteries
0.182 0.818 0.000
F63.9 Habit and impulse disorder, unspecified
0.182 0.818 0.000
F63.8 Other habit and impulse disorders
0.182 0.818 0.000
F63.3 Trichotillomania
0.182 0.818 0.000
F63.2 Pathological stealing [kleptomania]
0.182 0.818 0.000
F63.1 Pathological fire-setting [pyromania]
0.182 0.818 0.000
F63.0 Pathological gambling
0.182 0.818 0.000
F65.9 Disorder of sexual preference, unspecified
0.182 0.818 0.000
F65.8 Other disorders of sexual preference
0.182 0.818 0.000
F65.6 Multiple disorders of sexual preference
0.182 0.818 0.000
F65.5 Sadomasochism
0.182 0.818 0.000
F65.4 Paedophilia
0.182 0.818 0.000
F65.3 Voyeurism
0.182 0.818 0.000
F65.2 Exhibitionism
0.182 0.818 0.000
F65.1 Fetishistic transvestism
0.182 0.818 0.000
F65.0 Fetishism
0.182 0.818 0.000
F66.9 Psychosexual development disorder, unspecified
0.182 0.818 0.000
F66.8 Other psychosexual development disorders
0.182 0.818 0.000
F66.2 Sexual relationship disorder
0.182 0.818 0.000
F66.1 Egodystonic sexual orientation
0.182 0.818 0.000
F66.0 Sexual maturation disorder
0.182 0.818 0.000
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
0.182 0.818 0.000
F25.2 Schizoaffective disorder, mixed type
0.181 0.819 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.181 0.819 0.000
T37.5 Antiviral drugs
0.181 0.819 0.000
T37.4 Anthelminthics
0.181 0.819 0.000
T37.3 Other antiprotozoal drugs
0.181 0.819 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.181 0.819 0.000
T37.1 Antimycobacterial drugs
0.181 0.819 0.000
T37.0 Sulphonamides
0.181 0.819 0.000
F30 Manic episode
0.180 0.820 0.000
F62.8 Other enduring personality changes
0.179 0.821 0.000
F62.1 Enduring personality change after psychiatric illness
0.179 0.821 0.000
F62.0 Enduring personality change after catastrophic experience
0.179 0.821 0.000
F06.3 Organic mood [affective] disorders
0.178 0.822 0.000
F48.0 Neurasthenia
0.177 0.823 0.000
D16.7 Ribs, sternum and clavicle
0.001 0.824 0.176
I60.5 Subarachnoid haemorrhage from vertebral artery
0.176 0.824 0.000
F62.9 Enduring personality change, unspecified
0.174 0.825 0.000
F81.9 Developmental disorder of scholastic skills, unspecified
0.174 0.826 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.173 0.827 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.173 0.827 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.173 0.827 0.000
F44.8 Other dissociative [conversion] disorders
0.172 0.827 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.172 0.828 0.000
D16.0 Scapula and long bones of upper limb
0.000 0.829 0.171
F25.9 Schizoaffective disorder, unspecified
0.171 0.829 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.171 0.829 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.171 0.829 0.000
F50.8 Other eating disorders
0.170 0.830 0.000
F50.5 Vomiting associated with other psychological disturbances
0.170 0.830 0.000
F50.4 Overeating associated with other psychological disturbances
0.170 0.830 0.000
F50.3 Atypical bulimia nervosa
0.170 0.830 0.000
F50.1 Atypical anorexia nervosa
0.170 0.830 0.000
D11.9 Major salivary gland, unspecified
0.001 0.830 0.169
F53.0 Mild mental and behavioural disorders associated with the puerperium, not elsewhere classified
0.169 0.831 0.000
F44.7 Mixed dissociative [conversion] disorders
0.169 0.831 0.000
F44.6 Dissociative anaesthesia and sensory loss
0.169 0.831 0.000
F44.3 Trance and possession disorders
0.169 0.831 0.000
F44.2 Dissociative stupor
0.169 0.831 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.